News
Norfolk and Norwich University Hospitals have been using two Mostcare Up devices since 2019 Norfolk and Norwich University Hospitals have been using two Mostcare Up devices since 2019 The complex ...
Treatment concerns adults and adolescents with stage IIB or IIC melanoma skin cancer Treatment concerns adults and adolescents with stage IIB or IIC melanoma skin cancer MSD’s Keytruda has received a ...
Data reinforces potential to deliver new standards across HER2-targetable breast cancer Data reinforces potential to deliver new standards across HER2-targetable breast cancer AstraZeneca (AZ) is ...
The decision follows a recent recommendation from the European Medicines Agency’s human medicines committee The decision follows a recent recommendation from the European Medicines Agency’s human ...
The therapy treats adults with chronic hepatitis delta virus and compensated liver disease The therapy treats adults with chronic hepatitis delta virus and compensated liver disease Gilead Sciences ...
MDG1011 is a therapy which aims to improve outcomes for in patients with high-risk blood cancers MDG1011 is a therapy which aims to improve outcomes for in patients with high-risk blood cancers ...
Therapy involves patients with colorectal cancer at 20 medical centres Therapy involves patients with colorectal cancer at 20 medical centres XBiotech has announced the enrolment of the first patient ...
The new technology was safely trialled on 20 healthy volunteers for the first time ever The new technology was safely trialled on 20 healthy volunteers for the first time ever Researchers at the UK ...
Scientists demonstrated that AZD1236 halts oedema while reducing spinal cord breakdown at site of injury Scientists demonstrated that AZD1236 halts oedema while reducing spinal cord breakdown at the ...
The proposed changes could limit patients’s access to treatments and clinical trials The proposed changes could limit patients’s access to treatments and clinical trials The National Economic Research ...
The ODD will offer clinical development and commercialisation benefits that will strengthen the drug programme The ODD will offer clinical development and commercialisation benefits that will ...
Therapy targets the coronavirus PLPRO enzyme essential for the evasion of host immune response Therapy targets the coronavirus PLPRO enzyme essential for the evasion of host immune response Infex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results